Procurement Summary
Country: Macedonia
Summary: Medicines on a Hospital List and Commercial Drugs
Deadline: 30 Jul 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 122745980
Document Ref. No.: 12680/2025
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Povtorena Procurement for Cancelled Parts 05496 / 2025A10AC01 Human Insulin 100 IE / 1ml, 2 B05BA01 Solution for Parenteral Nutrition, Amino Acids 10% / 100 ml, 3 B05BA02 Fat Emulsions 20% / 100 ml (200mg / 1ml), 4 C01AA05 Digoxin 0.25mg, 5 C01DA08 ISOsorbide Dinitrate 5mg, 6 C03AA03 Hydro Chlorothiazide 25mg, 7 C03CA01 FUROSEMIDE 40 mg, 8 C08CA05 NIFEDIPINE 40mg, 9 C08CA05 NIFEDIPINE 20mg, 10 C08DA01 VERAPAMIL 5mg/2ml, 11 D07AC14 METHYLPREDNISOLONE 1mg/1g, 12 G01AF01 METRONIDAZOLE 500mg, 13 G01AF01 METRONIDAZOLE 400mg, 14 G02CB01 BROMOCRIPTINE 2, 5mg, 15 G03GB02 CLOMIFENE 50mg, 16 G04BD09 TROSPIUM 5mg, 17 J01CE10 BENZATHINE PHENOxYMETHYL PENICILLIN 1000000 IE, 18 J01CR02 AMOxICILLIN, CLAVULANIC ACID 156, 25 mg/5ml(125mg/31, 25mg)/5ml, 19 J01DC04 CEFACLOR 250mg/5ml, 20 J01DD04 CEFTRIAxONE 250 mg, 21 J01DE01 CEFEPIME 1 g(1000mg), 22 J01EE01 SULFAMETHOxAZOLE, TRIMETHOPRIM (400mg/80mg), 23 J01EE01 SULFAMETHOxAZOLE, TRIMETHOPRIM (200mg/40mg)/5ml, 24 J01FA01 ERYTHROMYCIN 250mg/5ml, 25 J01FA03 MIDECAMYCIN 400mg, 26 J01MA06 NORFLOxACIN 400mg, 27 J02AC01 FLUCONAZOLE 150mg, 28 L01BA01 METHOTRExATE 50mg/2ml, 29 L01BC02 5-FLUOROURACIL (1000mg/20ml)/50mg/1ml, 30 L01CD01 PACLITAxEL 30MG/5ML, 31 L01DB01 DOxORUBICIN l(2mg/1ml), 32 L01xA01 CISPLATIN 0.5mg/1 ml 50mg/100ml, 33 M01AE03 KETOPROFEN 100mg, 34 M01AE03 KETOPROFEN 100mg, 35 M03AC01 PANCURONIUM 4mg/2ml, 36 M03AC04 ATRACURIUM 50mg/5ml, 37 N01AH01 FENTANYL 0.1mg/2ml (0, 05mg/ml), 38 N01AH01 FENTANYL 0.5mg/10ml 0, 05mg/ml, 39 N01BB01 BUPIVACAINE 5mg/1ml 20ml, 40 R03AC02 SALBUTAMOL ...
CPV Descriptions: Pharmaceuticals
Documents
Tender Notice
Document_1.pdf
Document_2.docx
Document_3.docx
Document_4.pdf